Growth Metrics

Treace Medical Concepts (TMCI) Amortization of Deferred Charges (2020 - 2025)

Treace Medical Concepts' Amortization of Deferred Charges history spans 6 years, with the latest figure at $69000.0 for Q4 2025.

  • For Q4 2025, Amortization of Deferred Charges fell 8.0% year-over-year to $69000.0; the TTM value through Dec 2025 reached $292000.0, down 2.01%, while the annual FY2025 figure was $292000.0, 2.01% down from the prior year.
  • Amortization of Deferred Charges reached $69000.0 in Q4 2025 per TMCI's latest filing, down from $75000.0 in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $75000.0 in Q4 2022 to a low of $43000.0 in Q1 2021.
  • Average Amortization of Deferred Charges over 5 years is $65350.0, with a median of $74000.0 recorded in 2022.
  • Peak YoY movement for Amortization of Deferred Charges: plummeted 33.85% in 2021, then skyrocketed 74.42% in 2022.
  • A 5-year view of Amortization of Deferred Charges shows it stood at $43000.0 in 2021, then surged by 74.42% to $75000.0 in 2022, then fell by 1.33% to $74000.0 in 2023, then grew by 1.35% to $75000.0 in 2024, then decreased by 8.0% to $69000.0 in 2025.
  • Per Business Quant, the three most recent readings for TMCI's Amortization of Deferred Charges are $69000.0 (Q4 2025), $75000.0 (Q3 2025), and $74000.0 (Q2 2025).